Such DNA damage that occurs due to hyperthermal ablation may alter gene expression of immune markers in tumor cells, such as programmed death ligand–1 (PD-L1), a critical biomarker for immune checkpoint inhibitor (ICI) therapy [15]. The gene discussed is CD274; the disease is neoplasm.